Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-055401

Chief Scientific Officer sold 11,100 shares at $51.79 ($574,869)

  • Chief Scientific Officer acquired 11,100 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2020-10-16 Option exercise +11,100 $6.32 $70,152 11,779 D: show line 1 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-10-16 Sale −11,100 $51.79 $574,869 679 D: show line 2 in the form
Open-market sales · 11,100 sh · avg $51.79 · $574,869

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2020-10-16 Option exercise · Stock Option (Right to Buy) −11,100 267,000 D: show line 3 in the form
Loading xslF345X03/doc4.xml…